# OnCo record nct02659514 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02659514/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02659514", "NCT02659514" ;
  schema:name "Study of Poziotinib in Participants With HER2-Positive Metastatic Breast Cancer"@en ;
  schema:description "A phase 2 trial of Poziotinib in Breast cancer, run by Spectrum Pharmaceuticals, Inc, completed."@en ;
  schema:url <https://onco.cc/trials/nct02659514/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02659514> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/poziotinib/> ;
  onco:companies <https://onco.cc/companies/spectrum-pharmaceuticals/> .